Non-coding RNA and hematopoietic system development

EHA Library, Frank Speleman, 103656

Hematopoiesis: Normal and Reprogrammed

EHA Library, Kateri Moore, 103650

Generation and expansion of HSCs by microRNAs

EHA Library, Gerald de Haan, 103649

The role of long non-coding RNAs in cancer

EHA Library, Marta Montes, 103655

EHA20 José Carreras Award Young - Opening ceremony

EHA Library, Martina Muckenthaler, 103636

Whole exome sequencing of 278 chronic lymphocytic leukemia patients from the CLL8 trial uncovers driver mutations with clinical impact and their evolutionary history in cancer pathogenesis

EHA Library, Eugen Tausch, 103384

Assessment of intravenous ferric carboxymaltose versus oral iron sulphate in the management of preoperative anaemia: A prospective randomized controlled trial

EHA Library, Alhossain Khalafallah, 103383

Impact of a gain-of-function mutation of CXCR4 on haematopoiesis in mice

EHA Library, Christelle Freitas, 103382

APL of all risk groups is highly curable with a chemo-free combination of attenuated arsenic trioxide and ATRA

EHA Library, Alan Burnett, 103381

Perioperative thromboprophylaxis in patients with bleeding disorders

EHA Library, Cedric HERMANS, 103574

Longer-acting agents for the treatment of bleeding disorders

EHA Library, Johannes Oldenburg, 103573

Novel concepts for coagulation activation

EHA Library, James Morrissey, 103572

The role of PET in the management of DLBCL

EHA Library, Olivier CASASNOVAS, 103586

How does one work up an AML patient in the molecular era

EHA Library, Torsten Haferlach, 103570

Management of low risk MDS

EHA Library, Aristoteles Giagounidis, 103598

DLBCL: How much do we need to know at diagnosis?

EHA Library, Wolfram Klapper, 103585

Epigenetic targeting of AML

EHA Library, Ross Levine, 103569

Molecular classification of MDS

EHA Library, Luca Malcovati, 103597

Modeling splice factor mutations

EHA Library, Omar Abdel-Wahab, 103647

Alternative splicing alterations in cancer

EHA Library, Didier Auboeuf, 103646

Epigenetic profiles in in B-cell lymphomas: therapeutic implications

EHA Library, Rita Shaknovich, 103584

MDS stem cell biology

EHA Library, Petter Woll, 103596

Unraveling the molecular biology of normal karyotype AML

EHA Library, George Vassiliou, 103568

EFFECT OF BLEOMYCIN HYDROLASE GENE POLYMORPHISM ON LATE PULMONARY COMPLICATIONS OF TREATING HODGKIN LYMPHOMA

EHA Library, Ádám Jóna, 103410

ROLE OF TREATMENT ON THE DEVELOPMENT OF SECONDARY MALIGNANCIES IN PATIENTS WITH ESSENTIAL THROMBOCYTEMIA

EHA Library, Cristina Santoro, 103218

IMPACT OF PREVIOUS RITUXIMAB EXPOSURE IN FOLLICULAR LYMPHOMA PATIENTS INTENSIFIED WITH HIGH DOSE THERAPY AND AUTOLOGOUS STEM CELL TRANSPLANTATION: A RETROSPECTIVE ANALYSIS OF THE GELTAMO REGISTRY.

EHA Library, Ana Jiménez Ubieto, 103201

INTERNATIONAL CONTROL ROUND FOR DEEP SEQUENCING ANALYSIS OF BCR-ABL KINASE DOMAIN MUTATIONS IN 11 LABORATORIES FROM 7 EUROPEAN COUNTRIES

EHA Library, Thomas Ernst, 103183

BONE MARROW IS MORE SENSITIVE THAN PERIPHERAL BLOOD FOR DETECTION OF MRD IN CLL AND PROVIDES A MORE RELIABLE PREDICTION OF OUTCOME ACROSS DIFFERENT TREATMENTS

EHA Library, Andy Rawstron, 103177

SMAC MIMETICS KILL REFRACTORY PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA THROUGH PARALLEL INDUCTION OF APOPTOSIS AND NECROPTOSIS

EHA Library, Scott McComb, 103161

ACUTE AND CHRONIC RENAL FAILURE IN A PATIENT COHORT FROM THE SPANISH PNH REGISTRY

EHA Library, Ana Maria Villegas, 103141

A PHASE I/IIA STUDY OF THE HUMAN ANTI-CD38 ANTIBODY MOR202 (MOR03087) IN RELAPSED OR REFRACTORY MULTIPLE MYELOMA

EHA Library, Marc S. Raab, 103053

OVERALL SURVIVAL ANALYSIS ADJUSTING FOR TREATMENT EFFECT AFTER CROSSOVER IN A PHASE 3 STUDY EVALUATING IDELALISIB IN COMBINATION WITH RITUXIMAB IN RELAPSED CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)

EHA Library, Paolo Ghia, 103166

CALCIUM INFLUX IS SHAPED BY THE MUTATIONAL STATUS IN CIRCULATING CD34+ CELLS OF PATIENTS WITH MYELOFIBROSIS

EHA Library, Vittorio Rosti, 103163

IMPACT OF STABLE DISEASE AS A RESPONSE TO POMALIDOMIDE PLUS LOW-DOSE DEXAMETHASONE ON SURVIVAL OUTCOMES IN PATIENTS WITH REFRACTORY OR RELAPSED AND REFRACTORY MULTIPLE MYELOMA IN THE MM-003 TRIAL

EHA Library, Philippe Moreau, 103056

NIVOLUMAB IN PATIENTS WITH RELAPSED OR REFRACTORY LYMPHOID MALIGNANCIES AND CLASSICAL HODGKIN LYMPHOMA: UPDATED SAFETY AND EFFICACY RESULTS OF A PHASE 1 STUDY (CA209-039)

EHA Library, Philippe Armand, 103093

MEK INHIBITION IS A PROMISING THERAPEUTIC STRATEGY FOR MLL-REARRANGED INFANT ALL PATIENTS CARRYING RAS MUTATIONS

EHA Library, Mark Kerstjens, 103095

SECOND GENERATION TYROSINE KINASE INHIBITORS MITIGATE THE HIGH RISK OF DISEASE PROGRESSION IN CHRONIC MYELOID LEUKAEMIA PATIENTS WITH HIGH DIAGNOSTIC LEVELS OF CIP2A

EHA Library, Richard Clark, 103122

POLYMORPHISMS IN IMMUNOMODULATING GENES AND RISK OF INVASIVE ASPERGILLOSIS: RESULTS FROM THE ASPBIOMICS CONSORTIUM

EHA Library, Juan Sainz, 103129

RESULTS OF A FIRST-IN-HUMAN, PHASE 1/2 TRIAL OF ASP2215, A SELECTIVE, POTENT ORAL INHIBITOR OF FLT3/AXL, IN PATIENTS WITH RELAPSED OR REFRACTORY ACUTE MYELOID LEUKEMIA

EHA Library, Regina switzer, 103407

A SUBCUTANEOUSLY ADMINISTERED RNAI THERAPEUTIC (ALN-CC5) TARGETING COMPLEMENT C5 FOR TREATMENT OF PNH AND COMPLEMENT MEDIATED DISEASES: INTERIM PHASE 1 STUDY RESULTS IN HEALTHY VOLUNTEERS

EHA Library, Benny Sorensen, 103180

COMBINATION OF MINOR PAROXYSMAL NOCTURNAL HEMOGLOBINURIA CLONES AND LYMPHOCYTE TELOMERE LENGTH PREDICT RESPONSIVENESS TO IMMUNOSUPPRESSIVE THERAPY IN PEDIATRIC APLASTIC ANEMIA

EHA Library, Atsushi Narita, 103409

MULTIVARIATE ANALYSIS OF PFS FROM THE AETHERA TRIAL: A PHASE 3 STUDY OF BRENTUXIMAB VEDOTIN CONSOLIDATION AFTER AUTOLOGOUS STEM CELL TRANSPLANT FOR HL

EHA Library, Jan Walewski, 103064

CONSTITUTUIONAL GENETIC VARIATION AT HBS1L-MYB INFLUENCES WHETHER JAK2 V617F MUTATED MPN PRESENT WITH PV OR ET

EHA Library, William Tapper, 103076

POST-TRANSPLANT CARFILZOMIB (KYPROLIS

EHA Library, Andrzej J. Jakubowiak, 103224

CONCURRENT CREBBP AND KRAS MUTATIONS ARE ASSOCIATED WITH A DISMAL OUTCOME IN CHILDREN WITH HYPERDIPLOID LEUKEMIA IMPLYING A SYNERGISTIC FUNCTION IN RELAPSE EVOLUTION

EHA Library, Renate Panzer-Grumayer, 103102

THE LLR TAP ICICLLE TRIAL ASSESSING BIOLOGICAL RESPONSE TO IBRUTINIB IN CLL: IMMEDIATE DISEASE REDISTRIBUTION PRECEDES CELL CYCLE ARREST BY 2 WEEKS WITH REDUCED BONE MARROW INFILTRATION BY 6 MONTHS.

EHA Library, Andy Rawstron, 103132

IMPACT OF MAJOR ROUTE VERSUS UNBALANCED MINOR ROUTE KARYOTYPES AT DIAGNOSIS ON PROGNOSIS OF CML

EHA Library, Christian T.Dietz, 103147

DONOR-DERIVED, CD19-DIRECTED, CAR-MODIFIED T CELLS INFUSED AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION AS PRE-EMPTIVE DONOR LYMPHOCYTE INFUSION IN PATIENTS WITH CD19+ MALIGNANCIES

EHA Library, Partow Kebriaei, 103162

ASSOCIATION OF MIR29 RNA WITH RESPONSE AND SURVIVAL IN OLDER PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML) TREATED WITH AZACITIDINE (AZA) OR CONVENTIONAL CARE REGIMENS (CCR)

EHA Library, Kyle J.MacBeth, 103171

MEK AND PI3K-AKT INHIBITORS SYNERGISTICALLY TARGET HYPERACTIVATING IL7-RECEPTOR SIGNALING MUTATIONS IN T-CELL ACUTE LEUKEMIA

EHA Library, Kirsten Canté-Barrett, 103101

THE THROMBOPOIETIN RECEPTOR SUPPORTS PROLONGED JAK2 V617F DIMERIZATION AND ACTIVATION AND IS MORE SENSITIVE TO LOW JAK2 V617F LEVELS DUE TO LONG HALF-LIFE WHEN COMPARED TO EPOR AND G-CSFR

EHA Library, Vitalina Gryshkova, 103198

BENDAMUSTINE-CONTAINING REGIMEN (BEGEV) AS INDUCTION CHEMOTHERAPY PRIOR TO ASCT FOR RELAPSED/REFRACTORY HODGKIN LYMPHOMA

EHA Library, Rita Mazza, 103195

THE INTERNATIONAL PROGNOSTIC INDEX FOR PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL-IPI) – AN INTERNATIONAL META-ANALYSIS

EHA Library, Jasmin Bahlo, 103401

IMMUNOMODULATORY EFFECT OF VITAMIN D AFTER ALLOGENEIC STEM CELL TRANSPLANTATION (ALLOSCT): RESULTS OF A PROSPECTIVE MULTICENTER CLINICALTRIAL. ALOVITA; EUDRACT: 2010-023279-25

EHA Library, Jose Antonio Perez-Simon, 103170

AKT PHOSPHORYLATION AT SERINE 473 IS A POWERFUL NOVEL BIOMARKER IN ACUTE MYELOID LEUKAEMIA, AND IS RELATED TO PROTEIN PHOSPHATASE 2A (PP2A) INHIBITION BY CIP2A AND SETBP1

EHA Library, Richard Clark, 103172

ELTROMBOPAG ADDED TO STANDARD IMMUNOSUPPRESSION AS FIRST TREATMENT IN SEVERE APLASTIC ANEMIA

EHA Library, Danielle Townsley, 103174

EAC BCR-ABL1 ASSAY PERFORMANCE VALIDATION ON THE DPCR QS3D PLATFORM AND COMPARISON WITH OTHER DPCR PLATFORMS.

EHA Library, Alikian Mary, 103233

LOW IKZF1 EXPRESSION IS ASSOCIATED WITH FAVORABLE OUTCOME IN LENALIDOMIDE TREATED NEWLY DIAGNOSED MULTIPLE MYELOMA

EHA Library, Christian Langer, 103227

COMPREHENSIVE GENOMIC PROFILING OF A LARGE COHORT OF ACUTE MYELOID LEUKAEMIA TO DISSECT ITS GENOMIC AND PHENOTYPIC COMPLEXITY

EHA Library, Elli Papaemmanuil, 103179

GERMAN HODGKIN STUDY GROUP PHASE I TRIAL OF DOXORUBICIN, VINBLASTINE, DACARBAZINE, AND LENALIDOMIDE (AVD-REV) FOR ELDERLY HODGKIN LYMPHOMA PATIENTS ? FINAL ANALYSIS

EHA Library, Boris Böll, 103189

PREDICTORS OF DEEP MOLECULAR RESPONSE IN CHRONIC MYELOID LEUKEMIA PATIENTS TREATED FRONTLINE WITH IMATINIB MESYLATE: AN ANALYSIS BY THE GIMEMA CML WP

EHA Library, Fausto Castagnetti, 103193

MONOTHERAPY TREATMENT WITH A SINGLE DOSE OF THE CXCR4 ANTAGONIST BL-8040 AS A NOVEL METHOD FOR MOBILIZATION OF HUMAN HSPC AND MSC; RESULTS OF A PHASE I HEALTHY VOLUNTEERS STUDY

EHA Library, Yaron Pereg, 103210

A FUNDAMENTAL ROLE OF CXCR4 IN T-ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Diana Passaro, 103408

CELLULAR AND MOLECULAR CHARACTERIZATION OF ERYTHROID DEFECTS IN DIAMOND BLACKFAN ANEMIA

EHA Library, David Bodine, 103084

SAFETY AND EFFICACY OF THE BRUTON TYROSINE KINASE INHIBITOR IBRUTINIB IN PATIENTS WITH HAIRY CELL LEUKEMIA: INTERIM RESULTS OF A PHASE 2 STUDY

EHA Library, Jeffrey Jones, 103204

IDENTIFICATION OF FIP1L1-PDGFRA ASSOCIATING MOLECULE THAT LOCATES IN THE NUCLEUS AND AUGMENTS THE ACTIVITY OF FIP1L1-PDGFRA.

EHA Library, Takeshi Kondo, 103205

IBRUTINIB IN PREVIOUSLY TREATED PATIENTS WITH WALDENSTR

EHA Library, Steven Treon, 103223

SELECTIVE DEATH OF LEUKEMIC STEM CELLS INDUCED BY DEFERASIROX

EHA Library, Saar Shapira, 100686

EUROPEAN NETWORK NGS-PTL PRELIMINARY DATA: WHOLE EXOME SEQUENCING IDENTIFIES MUTATIONS OF ALDH2, RETSAT, HSPG2, CHPF, AND OTHER METABOLIC GENES AS A NOVEL FUNCTIONAL CATEGORY IN ACUTE MYELOID LEUKEMIA

EHA Library, Giorgia Simonetti, 100694

ADDITIONAL MOLECULAR ABERRATIONS LEADING TO LEUKEMIC TRANSFORMATION IN PATIENTS WITH FAMILIAL PLATELET DISORDER

EHA Library, Nicolas Duployez, 100687

LEUKEMOGENIC MLL-ENL FUSIONS INDUCE ALTERNATIVE CHROMATIN STATES TO DRIVE A FUNCTIONALLY DICHOTOMIC GROUP OF TARGET GENES.

EHA Library, Robert Slany, 100688

GENOMIC LANDSCAPE OF CORE-BINDING FACTOR ACUTE MYELOID LEUKEMIA

EHA Library, Nicolas Duployez, 100689

NEW JAK2 HETEROZYGOUS LOSS: A ROLE IN OVERALL SURVIVAL IN ACUTE MYELOID LEUKEMIA PATIENTS

EHA Library, Viviana Guadagnuolo, 100685

A DISTINCTIVE LONG-NON CODING RNA SIGNATURE CHARACTERIZES ACUTE MYELOID LEUKEMIA WITH TRANSLOCATION T(8;16)(P11;P13) AND MYST3-CREBBP REARRANGEMENT

EHA Library, Marina Diaz-Beya, 100684

IMPROVED SURVIVAL IN ADULT PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) IN THE NETHERLANDS: A POPULATION-BASED STUDY ON TREATMENT, TRIAL PARTICIPATION AND SURVIVAL, 1989-2012

EHA Library, Aniko Szabo, 100683

SIGNIFICANCE OF RECURRENCE OF MINIMAL RESIDUAL DISEASE (MRD) DETECTED BY MULTI-PARAMETER FLOW CYTOMETRY (MFC) IN PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) IN MORPHOLOGICAL REMISSION

EHA Library, Naveen Pemmaraju, 100682

OVEREXPRESSION OF INTEGRIN Α9 COOPERATES WITH THE LOSS OF RUNX1 AND RUNX3 IN LEUKEMOGENESIS

EHA Library, Desmond Chin, 100693

PRO-METASTASIS PHOSPHATASE PRL-3 TRANSFORMS LEUKEMIA STEM CELLS AND PROMOTES LEUKEMOGENESIS IN AML VIA ACTIVATION OF SOX4/LIN28B/LET-7 SIGNALING

EHA Library, Jianbiao Zhou, 100690

RATIONAL TARGETING OF NOTCH SIGNALLING IN ACUTE MYELOID LEUKAEMIA

EHA Library, Paul Takam Kamga, 100691

ARSENIC TRIOXIDE AND ALL-TRANS-RETINOIC ACID TARGET NPM1 MUTANT ONCOPROTEIN LEVELS AND INDUCE APOPTOSIS IN NPM1-MUTATED AML CELLS

EHA Library, Maria Paola Martelli, 100692

DEVELOPMENT OF AN NGS ASSAY FOR IGK THAT CAN BE COMBINED WITH IGH FOR IDENTIFYING CLONAL POPULATIONS IN LYMPHOID MALIGNANCIES

EHA Library, Niels Adams, 100681

HDAC EXPRESSION PATTERNS ASSOCIATE WITH HIGH-RISK FEATURES IN PEDIATRIC LEUKEMIA

EHA Library, Mireia Camós, 100680

OSTEONECROSIS IN AIEOP ALL 2000 AND 2006R TRIALS

EHA Library, Rosanna Parasole, 100679

NONE OF THE COMMON RISK FACTORS IS SIGNIFICANT IN T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA TREATED ACCORDING TO NON-INTENSIVE BUT NON-INTERRUPTIVE PROTOCOL ALL-2009: RESULTS OF THE RUSSIAN ALL STUDY GROUP

EHA Library, Elena Parovichnikova, 100678

EXTENSIVE PHENOTYPIC CHARACTERIZATION AND CYTOKINE PRODUCTION OF WHOLE BLOOD AT DAY 29 OF INDUCTION CHEMOTHERAPY FOR PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Nina Rolf, 100677

IKZF1 DELETION AND PROGNOSIS OF ADULTS WITH COMMON B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Qiu-Mei Yao, 100676

IMPACT OF STEROID DOSE AT INDUCTION PHASE OF PEDIATRIC ALL ON MINIMAL RESIDUAL DISEASE AND SURVIVAL OF THE PATIENTS: A PROSPECTIVE RANDOMIZED STUDY

EHA Library, Sule Unal, 100675

GENOME-WIDE ANALYSIS OF WDR5 BINDING REVEALS ITS EFFECT ON TUMORIGENESIS IN ACUTE LEUKEMIA

EHA Library, Zheng Ge, 100674

PROGNOSIS IN OLDER/ELDERLY PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKAEMIA DIAGNOSED 2005-2012: RESULTS FROM A SWEDISH POPULATION-BASED STUDY

EHA Library, Emma Bergfelt Lennmyr, 100673

A RARE SUBPOPULATION OF QUIESCENT, DRUG RESISTANT STEM CELLS IN PATIENTS' ALL CELLS GROWING IN MICE

EHA Library, Irmela Jeremias, 100672

PATIENT'S SINGLE STEM CELL CLONES OF ACUTE LYMPHOBLASTIC LEUKEMIA SHOW DRUG RESISTANCE AND SLOW PROLIFERATION IN MICE IN VIVO

EHA Library, Cornelia Finkenzeller, 100671

EXPRESSION OF GATA3 DEPENDS ON GENOTYPE VARIANT AT RS3824662 AND IS ASSOCIATED WITH CLINICAL COURSE OF B-CELL CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Joanna Madzio, 100670

XIAP EXHIBITS AN ESSENTIAL ROLE FOR PATIENTS’ ALL CELLS GROWING IN VIVO AS SHOWN BY A NOVEL TECHNIQUE FOR STABLE KNOCKDOWN IN PATIENT-DERIVED XENOGRAFT (PDX) ALL CELLS

EHA Library, Michela Carlet, 100669

DISTINCT ALL-ASSOCIATED JAK3 MUTANTS EXHIBIT DIFFERENT CYTOKINE-RECEPTOR REQUIREMENTS AND JAK-INHIBITOR SPECIFICITIES

EHA Library, Elisabeth Losdyck, 100668

INTEGRATED ANALYSIS OF JAK/STAT, RAS/AKT AND NOTCH1 PATHWAYS IN T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA: PROGNOSTIC AND THERAPEUTIC IMPLICATIONS

EHA Library, Valentina Gianfelici, 100667

CLONAL ORIGINS OF HIGH-HYPERDIPLOID ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Donat Alpar, 100666

JAK2 MUTATIONS ARE HIGHLY ENRICHED IN CRLF2-REARRANGED B-ALL CASES WITH A PH-LIKE GENE SIGNATURE

EHA Library, Teresa Sadras, 100665

IL-7 ACTIVATES THE JAK/STAT5/PIM1 KINASE AXIS THEREBY MEDIATING VIABILITY AND GROWTH OF T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA CELLS

EHA Library, Daniel Ribeiro, 100664

MIR-146B IN T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA: A POSSIBLE TUMOR SUPPRESSOR ROLE

EHA Library, Rita Fragoso, 100663

SPHINGOSINE KINASES ARE REQUIRED FOR IL-7-MEDIATED SIGNALING IN T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Alice Melão, 100662